NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $223 | -8.6% | 6,158 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $244 | -99.9% | 6,158 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $287,000 | +6.3% | 6,158 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $270,000 | -39.3% | 6,158 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $445,000 | -10.8% | 6,158 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $499,000 | -30.4% | 6,158 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $717,000 | -29.8% | 6,158 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $1,021,000 | +25.0% | 6,158 | +5.1% | 0.01% | 0.0% |
| Q1 2021 | $817,000 | -37.5% | 5,858 | -22.5% | 0.01% | -37.5% |
| Q4 2020 | $1,308,000 | +24.2% | 7,558 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $1,053,000 | -7.3% | 7,558 | -20.6% | 0.01% | +60.0% |
| Q2 2020 | $1,136,000 | – | 9,516 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |